MedPath

Urinary Aquaporin 2 Excretion After NSAID in Fasting Healthy Human

Phase 4
Completed
Conditions
Healthy
Registration Number
NCT00281762
Lead Sponsor
Regional Hospital Holstebro
Brief Summary

We wanted to test the hypothesis that prostaglandin inhibition reduces the down regulation of u-AQP-2 induced by fasting

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
20
Inclusion Criteria
  • (1) Genders; both mal and female
  • (2) Age; 18- 65 years old
  • (3) BMI; below 30
  • (4) Females had to bee in oral contraceptive treatment
Exclusion Criteria
  • (1) Clinical signs or history of disease in the heart, lungs, kidneys or endocrine organs
  • (2) Abnormal laboratory test (blood haemoglobin, white cell count, platelets, plasma sodium, plasma potassium, plasma creatinine, plasma albumin, plasma bilirubin, plasma alanine aminotransferase, plasma cholesterol and blood glucose)
  • (3) Albuminuria or glucosuria
  • (4) Cancer
  • (5) Arterial hypertension
  • (6) Alcohol abuse
  • (7) Use of tobacco
  • (8) Medical treatment, except oral contraceptives
  • (9) Pregnancy or breast feeding
  • (10) Medicine abuse
  • (11) Donation of blood less than 1 month before the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
FeNa
U-AQP-2
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Medicine, Holstebro Hospital

🇩🇰

Holstebro, Denmark

© Copyright 2025. All Rights Reserved by MedPath